Výsledky vyhledávání - "Sarah B, Fisher"

Akademický článek

Durable local control with hypofractionated radiation therapy for unresectable or metastatic melanoma

Autor: Sydney A. Keatts, Aya F. Salem, David M. Swanson, Ahsan S. Farooqi, Andrew J. Bishop, Rodabe N. Amaria, Jennifer L. McQuade, Isabella C. Glitza Oliva, Adi Diab, Roi Weiser, Sarah B. Fisher, Ryan P. Goepfert, Merrick I. Ross, B. Ashleigh Guadagnolo, Devarati Mitra

Publikováno v: Clinical and Translational Radiation Oncology, Vol 49, Iss , Pp 100856- (2024)

Background and purpose: As patients with advanced melanoma live longer in the context of systemic therapy advancements, better strategies for durable control of bulky tumors are needed. In this study, we evaluated if dose-escalated hypofractionated r

Externí odkaz: https://doaj.org/article/3407e6df315b41fa937429310baf0c92

Zobrazit plný text záznamu

Akademický článek

A prospective feasibility study evaluating the 5x-multiplier to standardize discharge prescriptions in cancer surgery patients

Autor: Timothy P. DiPeri, MD, Timothy E. Newhook, MD, Ryan W. Day, MD, Yi-Ju Chiang, MSPH, Whitney L. Dewhurst, MS, AGNP-C, Elsa M. Arvide, MS, PA-C, Morgan L. Bruno, MS, ACNP-BC, Christopher P. Scally, MD, MS, Christina L. Roland, MD, MS, Matthew H.G. Katz, MD, Jean-Nicolas Vauthey, MD, George J. Chang, MD, MS, Brian D. Badgwell, MD, MS, Nancy D. Perrier, MD, Elizabeth G. Grubbs, MD, Jeffrey E. Lee, MD, Ching-Wei D. Tzeng, MD, Brian K. Bednarski, MD, Iris B. Chen, MS, APRN, Ryan J. Comeaux, MS, PA-C, Dana M. Cox, MPAS, PA-C, Barry W. Feig, MD, Sarah B. Fisher, MD, Keith F. Fournier, MD, Semhar J. Ghebremichael, MD, Heather M. Gibson, MS, PA-C, Nicole C. Gourmelon, MS, PA-C, Paul H. Graham, MD, Shannon Hancher, MD, Kelly K. Hunt, MD, Naruhiko Ikoma, MD, MPH, Shanae L. Ivey MPAS, PA-C, Emily Z. Keung, MD, Celia R. Ledet, MD, Angela R. Limmer, MS, PA-C, Paul F. Mansfield, MD, Lauren K. Mayon, MS, PA-C, Craig A. Messick, MD, Keyuri U. Popat, MD, Nikita F. Rajkot MPAS, PA-C, Justine L. Robinson MPAS, PA-C, Kristen A. Robinson MPAS, PA-C, Miguel A. Rodriguez-Bigas, MD, David A. Santos, MD, MS, John M. Skibber, MD, B. Bryce Speer, DO, Jose Soliz, MD, Matthew M. Tillman, MD, Keila E. Torres, MD, Antoinette van Meter, MD, Marla E. Weldon, MS, PA-C, Uduak Ursula Williams, MD, Y. Nancy You, MD, MHSc

Publikováno v: Surgery Open Science, Vol 9, Iss , Pp 51-57 (2022)

Background: We designed a prospective feasibility study to assess the 5x-multiplier (5x) calculation (eg, 3 pills in last 24 hours × 5 = 15) to standardize discharge opioid prescriptions compared to usual care. Methods: Faculty-based surgical teams

Externí odkaz: https://doaj.org/article/eb76d169a7434c548f83e4fa72a03946

Zobrazit plný text záznamu

Akademický článek

Hidradenocarcinoma involving the male breast: Report of a case with emphasis on the differential diagnosis of invasive carcinoma with sweat gland differentiation

Autor: Eun Young Kang, Sarah B. Fisher, Lavinia P. Middleton

Publikováno v: Human Pathology Reports, Vol 31, Iss , Pp 300698- (2023)

A 41-year-old male presented with a 2-month history of a palpable peri-areolar nodule in the right breast. The patient underwent an excisional biopsy, which revealed a solid and partially cystic mass in breast parenchyma with an infiltrative border c

Externí odkaz: https://doaj.org/article/26a0ca99d0ef40ad80813be6935029b5

Zobrazit plný text záznamu

Akademický článek

Neoadjuvant checkpoint inhibitor immunotherapy for resectable mucosal melanoma

Publikováno v: Frontiers in Oncology, Vol 12 (2022)

BackgroundNeoadjuvant checkpoint inhibition (CPI) has recently demonstrated impressive outcomes in patients with stage 3 cutaneous melanoma. However, the safety, efficacy, and outcome of neoadjuvant CPI in patients with mucosal melanoma (MM) are not

Externí odkaz: https://doaj.org/article/130631cb682140daaa725bf5649ba720

Zobrazit plný text záznamu

Advances in Endocrine Surgery

Autor: Michael S, Lui, Aditya S, Shirali, Bernice L, Huang, Sarah B, Fisher, Nancy D, Perrier

Publikováno v: Surgical Oncology Clinics of North America. 32:199-220

Recent changes in the landscape of endocrine surgery include a shift from total thyroidectomy for almost all patients with papillary thyroid cancer to the incorporation of thyroid lobectomy for well-selected patients with low-risk disease; minimally

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::682c35cd7e15864a9c50823822d1250c
https://doi.org/10.1016/j.soc.2022.08.004

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání